• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过光密度测定法对血管性血友病因子多聚体模式进行定量分析并促进比较。

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.

作者信息

Studt J D, Budde U, Schneppenheim R, Eisert R, von Depka Prondzinski M, Ganser A, Barthels M

机构信息

Department of Haematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.

出版信息

Am J Clin Pathol. 2001 Oct;116(4):567-74. doi: 10.1309/75CQ-V7UX-4QX8-WXE7.

DOI:10.1309/75CQ-V7UX-4QX8-WXE7
PMID:11601142
Abstract

The analysis of von Willebrand factor (vWF) multimers is an important laboratory tool for distinguishing among the numerous subtypes of von Willebrand disease (vWD). Comparability and reproducibility of this method are insufficient; standardization and external references are pending. Interlaboratory comparison of results therefore may be difficult. We applied densitometry to obtain a reproducible quantification of vWF multimer patterns in healthy donors, patients with vWD variants, and factor VIII/vWF concentrates to improve the reproducibility and comparability of vWF multimer analysis. Multimers were separated and visualized luminographically on x-ray films. Films were scanned and evaluated by densitometry. The variation inherent in vWF multimer analysis and the range of the normal could be quantified. In vWD variants and factor VIII/vWF concentrates, densitometry could quantify and visualize alterations of vWF multimer patterns and facilitate their comparison. Densitometry permits a precise quantitative comparison of sample patterns to a reference plasma. It could be a valuable tool offering reproducible quantification and additional visualization of normal and pathologic vWF multimer patterns, facilitating their comparison and contributing to a standardization of vWF multimer analysis.

摘要

血管性血友病因子(vWF)多聚体分析是区分多种血管性血友病(vWD)亚型的重要实验室工具。该方法的可比性和可重复性不足;标准化和外部参考仍悬而未决。因此,实验室间结果的比较可能很困难。我们应用光密度测定法对健康供体、vWD变异型患者以及凝血因子VIII/vWF浓缩物中的vWF多聚体模式进行可重复的定量分析,以提高vWF多聚体分析的可重复性和可比性。多聚体经分离后在X光片上进行发光成像显示。扫描X光片并通过光密度测定法进行评估。vWF多聚体分析中固有的变异以及正常范围可以被量化。在vWD变异型和凝血因子VIII/vWF浓缩物中,光密度测定法可以量化并显示vWF多聚体模式的改变,便于进行比较。光密度测定法能够将样本模式与参考血浆进行精确的定量比较。它可能是一种有价值的工具,可为正常和病理性vWF多聚体模式提供可重复的定量分析和额外的可视化显示,便于比较,并有助于vWF多聚体分析的标准化。

相似文献

1
Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.通过光密度测定法对血管性血友病因子多聚体模式进行定量分析并促进比较。
Am J Clin Pathol. 2001 Oct;116(4):567-74. doi: 10.1309/75CQ-V7UX-4QX8-WXE7.
2
Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.血管性血友病因子/凝血因子VIII浓缩物在血管性血友病治疗中的应用
Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. doi: 10.1097/MBC.0b013e3283254570.
3
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
4
Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.血管性血友病因子/凝血因子VIII浓缩物的比较分析与分类:对血管性血友病患者治疗的影响
Semin Thromb Hemost. 2006 Sep;32(6):626-35. doi: 10.1055/s-2006-949668.
5
Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.两种对血管性血友病因子低、中、高多聚体具有不同结合亲和力的血管性血友病因子胶原结合试验的比较。
Semin Thromb Hemost. 2002 Apr;28(2):139-48. doi: 10.1055/s-2002-27816.
6
Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.采用高分辨率和低分辨率垂直 SDS-琼脂糖凝胶电泳和 Cy5 标记抗体高灵敏度荧光检测同时分析血管性血友病因子多聚体。
Am J Clin Pathol. 2010 Feb;133(2):322-30. doi: 10.1309/AJCPZSBTD2BWOMVL.
7
Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.使用抗生物素蛋白-生物素过氧化物酶复合物通过免疫酶染色法观察血管性血友病因子多聚体。
Thromb Haemost. 1986 Apr 30;55(2):263-7.
8
Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging.凝胶免疫染色和红外荧光成像法进行血浆血管性血友病因子多聚体定量分析。
Thromb Res. 2010 Dec;126(6):543-9. doi: 10.1016/j.thromres.2010.09.015.
9
Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.血管性血友病的实验室检测:多聚体分析对诊断和分类的贡献
Semin Thromb Hemost. 2006 Jul;32(5):514-21. doi: 10.1055/s-2006-947866.
10
A comparative in vitro evaluation of six von Willebrand factor concentrates.六种血管性血友病因子浓缩物的体外比较评估
Haemophilia. 2004 May;10(3):243-9. doi: 10.1111/j.1365-2516.2004.00893.x.

引用本文的文献

1
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura.一种新型 von Willebrand 因子多聚体比值作为血栓性血小板减少性紫癜疾病活动的标志物。
Blood Adv. 2023 Sep 12;7(17):5091-5102. doi: 10.1182/bloodadvances.2023010028.
2
Establishing reference intervals for von Willebrand factor multimers.建立血管性血友病因子多聚体的参考区间。
J Med Biochem. 2022 Feb 2;41(1):115-121. doi: 10.5937/jomb0-31941.
3
Von Willebrand Factor Multimers and the Relaxation Response: A One-Year Study.
血管性血友病因子多聚体与松弛反应:一项为期一年的研究。
Entropy (Basel). 2021 Apr 10;23(4):447. doi: 10.3390/e23040447.
4
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.在疑似肝素诱导血小板减少症的危重症 COVID-19 患者中鉴定出血小板激活免疫复合物。
J Thromb Haemost. 2021 May;19(5):1342-1347. doi: 10.1111/jth.15283. Epub 2021 Mar 14.
5
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease.血管性血友病因子多聚体密度测定分析:血管性血友病临床准确性及临床意义的验证
Hemasphere. 2021 Feb 17;5(3):e542. doi: 10.1097/HS9.0000000000000542. eCollection 2021 Mar.
6
VAMP3 and SNAP23 as Potential Targets for Preventing the Disturbed Flow-Accelerated Thrombus Formation.VAMP3和SNAP23作为预防紊乱血流加速血栓形成的潜在靶点。
Front Cell Dev Biol. 2020 Nov 5;8:576826. doi: 10.3389/fcell.2020.576826. eCollection 2020.
7
Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers.两个欧洲中心对一种半自动血管性血友病因子多聚体检测方法——Hydragel 5血管性血友病多聚体检测法进行的评估。
Res Pract Thromb Haemost. 2018 Aug 12;2(4):790-799. doi: 10.1002/rth2.12141. eCollection 2018 Oct.
8
Gastrointestinal Bleeding in Native and Prosthetic Valve Disease.天然瓣膜病和人工瓣膜病中的胃肠道出血
Curr Treat Options Cardiovasc Med. 2018 Feb 3;20(1):6. doi: 10.1007/s11936-018-0595-1.
9
New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.评估循环中活性转化生长因子-β1 水平的新方法:在心衰评估和左心室辅助装置影响评估中的意义。
Transl Res. 2018 Feb;192:15-29. doi: 10.1016/j.trsl.2017.10.006. Epub 2017 Nov 5.
10
Von Willebrand disease: an overview.血管性血友病:概述
Indian J Pharm Sci. 2011 Jan;73(1):7-16. doi: 10.4103/0250-474X.89751.